Tofersen

Active substance  tofersen
Holder     Clinigen Healthcare Limited on behalf of Biogen
Status Running
Indication Amyotrophic Lateral Sclerosis (ALS) Associated with a Mutation in the Superoxide Dismutase 1 (SOD1) Gene
Public documents Approbation
  Information for the patient
  Informed consent
Last update 25/08/2023

 

Last updated on 13/02/2024